Peptron

087010.KQ

141.11 USD

-3.02

-2.10%

Overview

Last close

141.11 usd

Market cap

2.16B usd

52 week high

168.67 usd

52 week low

16.05 usd

Target price

25.76 usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

973.2909

Price/Book Value

30.5186

Enterprise Value

3.26B usd

EV/Revenue

1029.5877

EV/EBITDA

-17.5233

Key financials

Revenue TTM

4.28M usd

Gross Profit TTM

3.29M usd

EBITDA TTM

-7.90M usd

Earnings per Share

N/A usd

Dividend

N/A usd

Total assets

111.86M usd

Net debt

N/A usd

About

Peptron, Inc. engages in the development of peptide-based medicines. The company's technologies include long acting; and SmartDepot, an ultrasonic spray drying technology for the preparation of sustained release injectable microsphere formulation of drug. Its research and development products include Luphere Depot for prostate cancer, endometriosis, uterine fibroids, premenopausal breast cancer, and puberty; SR-Octreotide for the treatment of acromegaly; SR-Exenatide to treat type 2 diabetes; and SR-Exenatide (PT320) for Parkinson's and Alzheimer's disease. Peptron, Inc. was founded in 1997 and is headquartered in Daejeon, South Korea.